A European pharmaceutical distributor secures an exclusive licence for a branded drug in Spain. Months later, the same product arrives in Spanish pharmacies at a lower price – shipped from another EU member state by a parallel importer. The licence holder's first instinct is to enforce. The legal reality is considerably more nuanced.
Parallel import in Spain is governed by the principle of EU-wide exhaustion of intellectual property rights. Under which the rights holder loses the power to restrict further distribution once goods are placed on the market within the European Economic Area with the rights holder's consent. Spanish courts, led by the Tribunal Supremo (Supreme Court of Spain), apply this principle in conjunction with EU law. This means that a trademark, patent. Alternatively. Copyright owner cannot use national IP rights to block cross-border trade within the EEA unless specific exceptions. most notably the legitimate-reasons defence – apply. The practical outcome depends heavily on how consent is demonstrated, whether products have been repackaged, and whether quality standards have been altered.
This analysis covers the doctrinal foundations of exhaustion in Spain, the competing interpretations found in Spanish case law, the gap between statutory text and actual practice. Cross-border strategic considerations for international rights holders and parallel importers alike. Additionally, the outlook under evolving EU regulation.
Doctrinal foundations of IP rights exhaustion in Spain
Spain operates within the EU's harmonised intellectual property system. For trademarks, the exhaustion principle is embedded in EU trade mark legislation as transposed into Spanish trademark law. For copyright, the parallel framework appears in Spanish intellectual property legislation. Patent exhaustion follows the same EU-wide model. The unifying thread is geographic scope: exhaustion occurs at the level of the EEA, not at the national level and not globally.
The international exhaustion doctrine – under which placing goods on the market anywhere in the world would exhaust EU rights – was considered and rejected by the Court of Justice of the European Union. Spain, as an EU member state, is bound by that rejection. A rights holder who exports goods to a country outside the EEA retains full power to prevent re-importation of those goods into Spain or any other EU member state. This single distinction drives a substantial portion of parallel import litigation in Spain.
Within the EEA, however, the principle bites hard. Once a rights holder, or an entity economically linked to the rights holder, places goods on the market in any EEA country, the IP rights in all other EEA states are exhausted simultaneously. The practical consequence is that a trademark holder who sells goods in Germany cannot invoke Spanish trademark rights to prevent a trader from purchasing those goods in Germany and reselling them in Spain. This is the bedrock of the parallel import trade in consumer goods, pharmaceuticals, luxury products, and automotive spare parts across the peninsula.
The term "consent" is the critical lever. Under Spanish and EU doctrine, consent must be free and unambiguous. Placing goods on the market under legal compulsion – for example, as a result of a compulsory licence in another jurisdiction – does not constitute consent and does not trigger exhaustion. Spanish intellectual property legislation and the case law of the Tribunal Supremo confirm this position, which is especially relevant in pharmaceutical contexts where compulsory licensing regimes differ across markets.
The concept of economic links is equally decisive. Where a parent company and its subsidiary. Alternatively, a licensor and its licensee, place goods on the market. The rights holder's consent is treated as given, because the entity introducing the goods into the EEA channel was authorised to do so. Practitioners in Spain note that this analysis frequently determines whether exhaustion applies before any other argument is considered.
Competing interpretations in Spanish courts and the limits of the statutory text
The statutory text in Spanish trademark and IP legislation reads with apparent clarity: once goods are placed on the EEA market with consent, the rights holder cannot oppose further commercialisation. In practice, Spanish courts have navigated a series of contested boundaries that the statute does not resolve directly.
The repackaging line of cases produces the most active litigation. Pharmaceutical parallel importers routinely repackage products – changing outer carton labelling, affixing new barcodes, translating leaflets, and in some cases overprinting or relabelling with the importer's own trading name. Spanish courts, following EU guidance, apply a five-condition test before allowing a trademark holder to oppose repackaging. The conditions address whether repackaging is necessary to access the market, whether the trademark owner has received prior notice, whether the original quality of the product is unaffected. Whether the new packaging clearly identifies the repackager. Additionally, whether the repackaged presentation is not damaging to the trademark's reputation.
The Tribunal Supremo has clarified that all five conditions must be met cumulatively. Where a parallel importer skips prior notification – which is a procedural step that many smaller importers neglect – the trademark holder can successfully oppose commercialisation even if the underlying repackaging would otherwise be permissible. This gap between what the law permits in principle and what is achievable without procedural compliance is one of the most significant practical traps in Spanish parallel import practice.
A second contested area involves legitimate reasons to oppose commercialisation after exhaustion has technically occurred. Spanish trademark legislation, consistent with EU law. Preserves the rights holder's ability to oppose further commercialisation where there are legitimate reasons. particularly where the condition of goods has been impaired after they were placed on the market. Courts in Spain have found legitimate reasons in situations including: broken seals, altered secondary packaging, removal of batch numbers relevant to product recalls, and mixing of different product variants in a single repackaged unit.
There is, however, a sharp divergence in how Spanish courts treat image damage as a legitimate reason. Some courts have accepted that selling luxury goods through discount channels. even without physical alteration. can constitute a legitimate reason to oppose parallel importation, particularly where the rights holder has established a selective distribution system. Other decisions adopt a narrower reading, holding that price differentiation alone does not constitute impairment of condition. The Tribunal Supremo has moved toward the narrower view, but the issue resurfaces in sector-specific contexts and continues to generate litigation.
A third area of debate concerns consent implied by contractual silence. Where a rights holder sells goods to a distributor without expressly restricting the territory of resale, Spanish courts have generally held that this constitutes consent to EEA-wide exhaustion. Rights holders who attempt to rely on implied territorial restrictions face an uphill challenge. The practical lesson is that any licence or distribution agreement governed by or enforceable in Spain must contain explicit, unambiguous territorial limitations if the rights holder wishes to preserve the ability to oppose parallel importation. A Sociedad Anónima (SA) or Sociedad de Responsabilidad Limitada (SL) operating as a Spanish subsidiary of a foreign rights holder should not assume that internal group pricing policies translate into legally enforceable distribution restrictions without express contractual language.
The gap between statute and practice is also visible in trademark application and opposition proceedings. A rights holder who discovers parallel imports may be tempted to file a new trademark application in a narrower Nice classification category to cover the specific presentation used by the importer. Spanish law does not permit rights holders to use registration strategy as a back-door circumvention of the exhaustion principle. Opposition proceedings launched on the basis of a newly filed mark covering a presentation already on the EEA market will generally fail if the parallel importer can demonstrate that the original goods were placed on the market with consent. The IP registration process, and the Notario (Spanish civil law notary) authentication of commercial documents used in opposition, do not create substantive rights that override exhaustion. They document and certify – they do not generate new rights where exhaustion has already occurred.
For businesses considering their intellectual property strategy in Spain, the interplay between registration, contractual structure, and exhaustion doctrine requires integrated planning rather than sequential reactions to enforcement problems.
The cross-border dimension: EEA versus global supply chains
Spain's position as a gateway between the EU, Latin America, North Africa, and Anglophone markets creates a particular cluster of parallel import issues that rights holders operating globally encounter repeatedly.
Goods routed through Spain from non-EEA markets. A frequent scenario involves goods manufactured by an authorised licensee in a Latin American country. Shipped to Spain as an import. Additionally, then distributed into the wider EU market. Because the goods were placed on the market outside the EEA, exhaustion does not apply. The rights holder can prevent both importation into Spain and onward distribution within the EU. However, enforcement depends on the rights holder's ability to prove that the specific goods in circulation originated outside the EEA. Spanish customs authorities cooperate with rights holders under EU customs enforcement mechanisms, and an application for border detention of suspected parallel imports from non-EEA sources is a practical first step. The administrative process requires prior registration of the relevant IP rights. trademark, patent. Alternatively. Copyright. in the Registro Mercantil (Spanish Commercial Register) is not the relevant body for IP rights. trademarks are registered with the Oficina Española de Patentes y Marcas (Spanish Patent and Trademark Office). Customs detention applications are filed with Spanish customs, referencing the IP registration records.
Goods originating in the EEA and re-exported, then re-imported. A subtler scenario involves goods that were lawfully placed on the EEA market. Exported to a non-EEA country. for example, for sale in the Middle East or North Africa. and then re-imported into Spain by a third party seeking to exploit the price differential. Spanish courts have accepted that re-importation of goods that left the EEA can be opposed. Because the export constituted a new placement outside the EEA area in circumstances that deprive the original EEA sale of its exhaustion effect. This reasoning is contested where the goods never actually reached the non-EEA buyer and were diverted back before delivery, but the general principle is established in Spanish and EU jurisprudence.
The pharmaceutical sector. Spain's pharmaceutical market is subject to price regulation, which historically produced significant price differentials between Spain and northern European member states. For decades, Spain was a source market for pharmaceutical parallel exports – licensed products priced lower in Spain were purchased and exported northward. The regulatory adjustments of recent years have reduced but not eliminated those differentials. For pharmaceutical rights holders, the interplay between compulsory pricing regulation, marketing authorisation requirements, and the exhaustion doctrine means that opposing parallel trade in medicines requires simultaneous analysis of IP law, pharmaceutical regulation, and competition law. A rights holder that attempts to oppose parallel trade by leveraging supply constraints. restricting the volume supplied to Spanish wholesalers to prevent export. must navigate EU competition law. This has found such conduct abusive in comparable situations. The strategic space is narrow.
Luxury goods and selective distribution. Spain has a well-developed retail market for luxury goods, and selective distribution systems are common. The interaction between exhaustion and selective distribution in Spain follows EU law: a rights holder operating a qualifying selective distribution network can, in principle, oppose sales outside authorised channels. However, once goods have been placed on the EEA market by an authorised distributor – even in breach of that distributor's contractual obligations – the trademark rights are exhausted as against third parties. The remedy for breach of the distribution agreement is contractual, not IP-based. A rights holder cannot use an infringement claim against the third-party parallel importer when the exhaustion has already occurred, regardless of how the goods left the authorised distribution channel. This is a source of repeated miscalculation by brands that conflate their contractual rights against distributors with their IP rights against market intermediaries.
Businesses that operate across multiple regulatory environments. including those with exposure to technology and AI law in Spain. increasingly encounter IP exhaustion issues in digital product contexts. There. The application of traditional exhaustion doctrine to software licences and digital content is actively evolving.
To receive an expert assessment of your parallel import position or IP rights exhaustion exposure in Spain, contact us at info@ferrazwhitmore.com.
Strategic implications for rights holders and parallel importers
The doctrinal clarity of exhaustion principle conceals a substantial layer of strategic complexity. For both rights holders and parallel importers, the difference between a winning and losing position in Spain frequently turns on preparation done months or years before litigation arises.
For rights holders seeking to contain parallel imports:
- Distribution agreements must contain explicit, enforceable territorial restrictions and resale limitations. A clause that is ambiguous or that contradicts the broader commercial relationship will be construed against the drafter by Spanish courts.
- Where repackaging is anticipated – as in pharmaceuticals and certain consumer goods – rights holders should establish a clear notification protocol and document the conditions under which repackaging will be accepted. Proactive engagement reduces uncertainty and creates a factual record for future enforcement.
- The Nice classification of trademark registrations should be reviewed against the actual product range and the likely presentations used by parallel importers. An IP registration that does not cover the precise class of goods or services involved will not support an infringement claim, regardless of the commercial reality.
- Customs recordal of IP rights is an underused tool in Spain. Border detention gives rights holders a 10-working-day window to obtain a court order or initiate proceedings. Without prior customs recordal, the window does not open.
For parallel importers operating in Spain:
- Prior notice to the rights holder before placing repackaged goods on the market is not optional courtesy – it is a legal condition of the right to repackage. Failure to give notice is a standalone ground for injunction regardless of whether the repackaging itself is otherwise compliant.
- Documentary evidence of EEA origin – invoices, shipping documents, batch traceability records – should be retained for every consignment. In an infringement claim, the burden of demonstrating consent and EEA origin falls on the importer once the rights holder has established a prima facie case.
- The use of a Notario to authenticate commercial documents establishing provenance and consent is a recognised best practice in Spanish parallel import disputes. Notarially authenticated records carry evidential weight in both commercial court proceedings and before the Tribunal Supremo on appeal.
The economics of a parallel import position require sober evaluation. The margin available from price differentials within the EEA has narrowed for many product categories as a result of market convergence. The cost of defending against a well-resourced rights holder – through opposition proceedings, customs detention challenges, and civil injunctions – can outpace commercial returns in lower-margin segments. Conversely, rights holders who invest heavily in enforcement against importers who are operating within the legal rules incur litigation cost without IP protection benefit. While potentially exposing themselves to competition law scrutiny if their enforcement strategy has the effect of partitioning the internal market.
The break-even analysis for enforcement versus tolerance therefore varies by sector, margin, and the strength of the rights holder's documentary case. Practitioners in Spain consistently note that the cases most likely to succeed for rights holders are those where repackaging defects. Lack of prior notice. Alternatively, non-EEA origin can be demonstrated clearly and early. before a contested hearing on the substantive exhaustion question.
A parallel perspective arises in Portugal, where the doctrinal foundations are similar but the procedural context and the role of arbitration differ. Clients operating across both Iberian markets should consider a coordinated approach; our analysis of parallel import and IP exhaustion in Portugal addresses those country-specific dimensions.
Regulatory outlook and the digital dimension
The exhaustion doctrine as applied in Spain is unlikely to undergo fundamental revision in the near term. The EU legislative regime has stabilised around EEA-wide exhaustion, and the Court of Justice of the European Union has shown no inclination to revisit the rejection of international exhaustion. The strategic variable is the digital product context, where the application of exhaustion to downloaded software, digital media, and tokenised assets remains contested.
Spanish courts have addressed the resale of used software licences in line with EU jurisprudence, which permits the resale of lawfully downloaded software under specific conditions. The rights holder cannot oppose the transfer of a used licence where the original copy has been rendered unusable. This principle, while established, produces significant practical complexity where cloud-based and subscription-licensed products are involved. The technical architecture of modern SaaS products is frequently designed in ways that make the transfer of a used licence practically impossible. which raises the question of whether the design itself constitutes a circumvention of exhaustion rights. Spanish law has not yet resolved this question directly, and it is an area where legislative or judicial development is anticipated.
The application of exhaustion principles to AI-generated works and AI-embedded products is an emerging issue. Where an AI system produces output that incorporates protected elements from a training dataset. Additionally, that output is then placed on the EEA market. The question of whether the placement exhausts rights in the underlying works is currently unanswered in Spain and across the EU. Rights holders in the technology sector should monitor regulatory and judicial developments closely. The EU AI Act introduces layered obligations for high-risk AI systems and general-purpose AI models, but does not directly address IP exhaustion. The interaction between the two regimes will require careful legal mapping as AI-embedded products become more common in Spanish and European markets.
For trademark practitioners, the Oficina Española de Patentes y Marcas (Spanish Patent and Trademark Office) continues to process trademark applications under Nice classification standards. Additionally. Opposition proceedings remain the primary administrative tool for rights holders seeking to prevent registration of marks used in parallel import contexts. The strategic use of opposition proceedings. particularly where a parallel importer attempts to register a mark incorporating the rights holder's brand elements in a new presentation. is a recognised defensive tool. Though its interaction with exhaustion doctrine limits its effectiveness once goods are already in circulation.
For a tailored strategy on parallel import management or IP rights protection in Spain, reach out to info@ferrazwhitmore.com.
Self-assessment: when exhaustion applies and when it does not
The exhaustion principle in Spain is applicable if all of the following conditions are met:
- The goods bearing the relevant IP rights were placed on the market within the EEA by the rights holder or with the rights holder's express or implied consent.
- The entity introducing the goods into the EEA market was authorised to do so – either directly as the rights holder, or as an economically linked subsidiary, licensee, or authorised distributor.
- The goods have not been materially altered or impaired after placement on the market.
- No legitimate reasons – as defined by Spanish and EU case law – exist to oppose further commercialisation.
Before relying on exhaustion as a defence or as a basis for parallel import activity in Spain, verify the following:
- Can the EEA origin of the specific goods be documented through a complete chain of title? Customs invoices, transport records, and batch numbers should be preserved.
- If repackaging is involved, has prior written notice been given to the rights holder? Has the repackaging been documented with photographic and notarial evidence?
- Does any contractual arrangement between the importer and its supplier contain a territorial restriction that could affect the consent analysis?
- Are the goods subject to sector-specific regulation – pharmaceutical marketing authorisation, cosmetics labelling requirements, or product safety certification – that independently restricts commercialisation regardless of IP exhaustion?
Conversely, a rights holder considering enforcement should verify:
- Is there evidence that the goods originated outside the EEA – invoices, production records, supply chain documentation – that would establish that exhaustion has not occurred?
- Has the importer complied with the repackaging notification requirement? If not, this procedural failure alone supports injunctive relief.
- Does the specific IP registration cover the precise goods and presentation at issue? An infringement claim built on a registration that does not map to the infringing goods will fail on standing.
- Is the enforcement strategy consistent with EU competition law? A pattern of market partitioning through IP enforcement may attract regulatory scrutiny independent of the IP dispute.
Frequently asked questions
Q: Can a Spanish trademark holder block goods that were first sold in Germany from being resold in Spain?
A: Generally, no. Under the EEA-wide exhaustion principle applied by Spanish courts and the Tribunal Supremo, placing goods on the market in any EEA member state with the rights holder's consent exhausts IP rights across the entire EEA. The trademark holder cannot use Spanish trademark rights to prevent parallel imports from Germany unless specific exceptions apply. such as evidence that the goods have been altered. That the importer failed to provide prior notice before repackaging. Alternatively, that there are other legitimate reasons recognised under Spanish and EU law.
Q: How long does an IP infringement action against a parallel importer typically take in Spain?
A: First-instance commercial court proceedings in Spain typically run from 12 to 24 months, depending on the complexity of the case and the court's caseload. Interim injunctions can be obtained more quickly – within days or weeks in urgent cases – but the rights holder must provide substantial evidence of infringement and risk of harm to secure provisional measures. Appeals to the Audiencia Provincial and potential further review by the Tribunal Supremo can extend the total timeline by several additional years. This duration is a significant factor in the economics of enforcement for lower-margin parallel import disputes.
Q: Is it a misconception that repackaging a product always allows a parallel importer to override trademark rights?
A: Yes. Repackaging does not automatically override a trademark holder's rights. Spanish and EU law impose strict cumulative conditions: repackaging must be necessary to market the product in Spain, the rights holder must receive prior written notice. The original product quality must be unaffected, the repackager's identity must be clearly stated on the new packaging. Additionally, the new presentation must not damage the trademark's reputation. Failure to meet any single condition. most often the prior notice requirement. gives the trademark holder a valid basis to oppose commercialisation of the repackaged goods. Even where the substantive product is identical to one lawfully sold in another EEA state.
About Ferraz & Whitmore
Ferraz & Whitmore is an international law firm based in Lisbon, advising business clients across 46 jurisdictions. Our intellectual property practice combines Portuguese civil law expertise with English common law tradition to deliver integrated IP strategies across the EEA and beyond. We advise rights holders, parallel importers, distributors. Additionally, technology companies on trademark application and registration, opposition proceedings. Nice classification strategy, IP enforcement. Additionally, the full spectrum of parallel import and rights exhaustion issues in Spain and across European markets. As a law firm in Spain and Portugal with dual-tradition capabilities, we work with international entrepreneurs, institutional investors, and in-house legal teams who require results-oriented counsel across multiple legal systems. Our attorneys have advised on cross-border IP matters before Spanish commercial courts, the Tribunal Supremo. Additionally. The Oficina Española de Patentes y Marcas. Additionally, the firm is active in leading international IP practice groups focused on cross-border enforcement and digital rights. Engaging a lawyer in Spain with cross-border IP experience is essential where parallel import disputes intersect with EU competition law and pharmaceutical regulation. To discuss your situation, contact us at info@ferrazwhitmore.com.
Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.